Gmo Benchmark-free is trading at 29.52 as of the 6th of September 2025; that is 0.31% up since the beginning of the trading day. The fund's open price was 29.43. Gmo Benchmark-free has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 8th of June 2025 and ending today, the 6th of September 2025. Click here to learn more.
The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation Fund. GMO Benchmark-Free is traded on NASDAQ Exchange in the United States. More on Gmo Benchmark Free Allocation
Gmo Benchmark Free Allocation [GBMSX] is traded in USA and was established 6th of September 2025. Gmo Benchmark-free is listed under GMO category by Fama And French industry classification. The fund is listed under World Allocation category and is part of GMO family. Gmo Benchmark Free currently has accumulated 3.86 B in assets under management (AUM) with no minimum investment requirements with the current yeild of 0.06%, while the total return for the last 3 years was -0.12%.
Check Gmo Benchmark-free Probability Of Bankruptcy
Instrument Allocation
Top Gmo Benchmark Free Allocation Mutual Fund Constituents
Gmo Benchmark-free financial ratios help investors to determine whether GMO Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GMO with respect to the benefits of owning Gmo Benchmark-free security.